COSTA MESA, Calif.--(BUSINESS WIRE)--Synthetic Blood International, Inc. (OTCBB:SYBD) lead product Oxycyte® is the subject of an article in today’s Miami Herald. The article appears in the paper’s health section under the headline: “Artificial blood goes from science fiction to science fact.” Oxycyte is the company’s perfluorocarbon (PFC) therapeutic oxygen carrier and blood substitute.
